ImmunoPrecise Antibodies Ltd. Cash Flow Reinvestment Rate

Latest as of October 2020: 1.62x

ImmunoPrecise Antibodies Ltd. cash flow reinvestment rate. ImmunoPrecise Antibodies Ltd. (HYFT) has a Cash Flow Reinvestment Rate of 1.62x as of October 2020, reinvesting $715.21K (capex $715.21K ) from operating cash flow of $440.23K. Explore how well can ImmunoPrecise Antibodies Ltd. service its debt to assess how comfortably operating cash covers total debt obligations.

Reinvestment Rate

1.62x

(Capex + Investments) / Operating CF

Total Reinvested

$715.21K

Capex + Investments

Operating Cash Flow

$440.23K

USD

Capital Expenditures

$715.21K

USD

Cash Flow Reinvestment Rate of ImmunoPrecise Antibodies Ltd. (2016–2016)

Cash flow reinvestment rate of ImmunoPrecise Antibodies Ltd. from 2016 to 2016. Historical reinvestment intensity for ImmunoPrecise Antibodies Ltd. across 1 annual periods. Explore ImmunoPrecise Antibodies Ltd. (HYFT) reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

ImmunoPrecise Antibodies Ltd. Cash Flow Reinvestment Rate by Year (2016–2016)

ImmunoPrecise Antibodies Ltd. cash flow reinvestment rate by year from 2016 to 2016. Year-by-year capital reinvestment analysis for ImmunoPrecise Antibodies Ltd.. For the full cash flow conversion analysis, see ImmunoPrecise Antibodies Ltd. operating cash flow efficiency.

Year	Reinvestment Rate	Total Reinvested (USD)	Operating CF	Capex	YoY Change
2016	0.06x	$17.48K	$284.09K	$17.48K	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow